title: A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?
authors.affiliation: Department of Medicine, Medical University of South Carolina, Charleston.
authors.forename: E C
authors.initials: EC
authors.lastname: Leroy
authors.forename: E A
authors.initials: EA
authors.lastname: Smith
authors.forename: M B
authors.initials: MB
authors.lastname: Kahaleh
authors.forename: M
authors.initials: M
authors.lastname: Trojanowska
authors.forename: R M
authors.initials: RM
authors.lastname: Silver
mesh_terms: D006801:Humans; D010982:Platelet-Derived Growth Factor / Q000378:metabolism / Q000502:physiology; D012595:Scleroderma, Systemic / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D015291:Transforming Growth Factors / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism / Q000502:physiology
chemical_list: D010982:Platelet-Derived Growth Factor; D014409:Tumor Necrosis Factor-alpha; D015291:Transforming Growth Factors